1)metastatic thyroid carcinoma甲状腺转移癌
1.Objectives:To explore the ultrasonic findings of metastatic thyroid carcinoma and to evaluate the diagnostic value of the ultrasonic imaging for patients with metastatic thyroid neoplasm.目的:探讨甲状腺转移癌的超声表现及诊断价值。
英文短句/例句
1.Clinical analysis of biological characteristics about matastatic carcinoma of thyroid甲状腺转移癌的临床生物学特征分析
2.Analysis on the MRI diagnosis of lymph node metastasis in thyroid carcinoma甲状腺癌转移淋巴结的MRI诊断分析
3.Analyse to Cervical Lymph Nodes Metastatic Trait of 185 Patients with Thyroid Papillocarcinoma甲状腺乳头状癌颈淋巴结转移特点185例分析
4.Investigation on Fourier Transform Infrared Spectrum of Metastatic Lymph Node in Thyroid Cancer甲状腺癌转移性淋巴结的红外光谱研究
5.Pattern of cervical lymph node metastasis in well-differentiated thyroid carcinoma分化型甲状腺癌的颈部淋巴结转移规律探讨
6.Effect of ~(131)I therapy on differentiated thyroid carcinoma metastases~(131)I治疗分化型甲状腺癌转移灶疗效观察
7.Relationship between Expression of VEGF-C and MMP-2 in Thyroid Papillary Cancer and Lymphoid Metastasis;甲状腺乳头状腺癌VEGF-C和MMP-2的表达及淋巴结转移相关性研究
8.MRI Diagnosis of Metastatic Lymph Nodes of Well-differentiated Thyroid Carcinoma and Its Metastatic Trend分化型甲状腺癌转移淋巴结的MRI诊断及转移趋势研究
9.Analysis of Relevant Factors in Lymph Node Metastasis of Papillary Thyroid Carcinoma;cN_0甲状腺乳头状癌颈部淋巴结转移的相关因素分析
10.Study of the Molecular Markers for the Neck Lymphatic Metastasis of the Patients with the No Stage of Papillary Thyroid Carcinoma;N_0期甲状腺乳头状癌颈淋巴结转移的分子标志物研究
11.Relationship between CXCL12-CXCR4 Biological Axis and Papillary Thyroid Cancer Lymph Node Metastasis;CXCL12-CXCR4生物学轴与甲状腺乳头状癌淋巴转移的相关性研究
12.Expression of COX-2 and VEGF-C in papillary thyroid carcinoma and their relationship to cervical lymph metastasesCOX-2和VEGF-C在甲状腺乳头状癌中的表达及与颈淋巴结转移的关系
13.Relationship between micro-lymphatic vessel density and lymphatic metastasis in follicular thyroid carcinoma甲状腺滤泡状癌微淋巴管密度与淋巴结转移的关系
14.The clinical value of lymph node micrometastases in central lymph node group in follicular carcinoma of thyroid甲状腺滤泡状癌淋巴结微转移与中央组淋巴结处理的探讨
15.Correlativity of Lymph Node Micrometastases Detection in Follicular Carcinoma of Thyroid in Different Risk Group甲状腺滤泡状癌危险组与淋巴结微转移的相关性
16.Effect of metastasis of expression on intratumour MVD and AKT_1,AKT_2 in thyroid papillary carcinoma甲状腺乳头状癌AKT_1、AKT_2表达及对微血管生成和肿瘤转移的影响
17.uPA, β-Catenin Expression Status and Microvessel Density Correlated to Invasion and Metastasis in Thyroid Carcinoma;uPA、β-连环素蛋白表达及MVD与甲状腺癌侵袭转移的关系
18.Imageology Evaluation and Molecular Biology Study on Cervical Lymph Node Metastasis of Thyroid Carcinoma;甲状腺癌颈淋巴结转移的影像学评估和相关分子生物学研究
相关短句/例句
Thyroid metastasis甲状腺转移
1.Individualized treatment was important to thyroid metastasis.目的:研究甲状腺转移癌的临床生物学特征,探讨其发病特点、诊断及治疗。
3)thyroid cancer甲状腺癌
1.New clinical characteristics of thyroid cancer:clinic research on 572 cases;甲状腺癌临床诊治新特点(附572例临床分析)
2.Application of SELDI-TOF-MS technology analyzing serum protein profiling in diagnosis of thyroid cancer;表面增强激光解吸电离-飞行时间质谱在甲状腺癌诊断及临床分期中的应用
3.The clinical analysis of reoperation of recurrent thyroid cancer;复发性甲状腺癌的再手术分析(附15例临床报告)
4)Thyroid carcinoma甲状腺癌
1.Ultrasonography diagnosis of thyroid carcinoma to cervical lymph nodes;高频二维超声及彩色多普勒对甲状腺癌颈部淋巴结转移的诊断价值
2.Respiratory nursing in perioperative nursing of patient with thyroid carcinoma;甲状腺癌患者围手术期的呼吸道护理
3.Expression and clinical significance of Tiam 1 in thyroid carcinoma;甲状腺癌中Tiam 1的表达及临床意义(英文)
5)carcinoma of thyroid甲状腺癌
6)thyroid adenocarcinoma甲状腺腺癌
延伸阅读
正常人白细胞转移因子 , 白细胞转移因子,转移因子药物名称:转移因子英文名:Transfer Factor别名: 正常人白细胞转移因子 , 白细胞转移因子,转移因子外文名:Transfer Factor ,TF适应症: 为细胞免疫反应增强剂,能将细胞免疫活性转移给受体,以提高受体的免疫功能。临床上用于治疗某些抗生素难以控制的病毒性或酶菌性细胞内感染(如带状皰疹、流行性乙型脑炎、白色念珠菌感染等)。对恶性肿瘤可作为辅助治疗剂,对自体免疫性疾病也有一定治疗作用。 用量用法: 一般采用皮下注射,注于上臂内侧或大腿内侧腹股沟下端,1次注射1支,每周1~2次,1个月后改为每2周1次。对带状疱疹,一般只需注射1次。 规格: 注射液:每支2ml,相当于1×1000000000白细胞提取物(上海产),北京产则相当于5~10×1000000000. 注:严禁静脉给药.类别:免疫调节剂
